| Product Code: ETC13347101 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Precision Pathology Cancer Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Precision Pathology Cancer Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Precision Pathology Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 North America Precision Pathology Cancer Market - Industry Life Cycle |
3.4 North America Precision Pathology Cancer Market - Porter's Five Forces |
3.5 North America Precision Pathology Cancer Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Precision Pathology Cancer Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 North America Precision Pathology Cancer Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.8 North America Precision Pathology Cancer Market Revenues & Volume Share, By Technology Used, 2021 & 2031F |
3.9 North America Precision Pathology Cancer Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
4 North America Precision Pathology Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Precision Pathology Cancer Market Trends |
6 North America Precision Pathology Cancer Market, 2021 - 2031 |
6.1 North America Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Precision Pathology Cancer Market, Revenues & Volume, By Biomarker Testing, 2021 - 2031 |
6.1.3 North America Precision Pathology Cancer Market, Revenues & Volume, By Molecular Testing, 2021 - 2031 |
6.1.4 North America Precision Pathology Cancer Market, Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031 |
6.1.5 North America Precision Pathology Cancer Market, Revenues & Volume, By Imaging Techniques, 2020 - 2028 |
6.2 North America Precision Pathology Cancer Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Precision Pathology Cancer Market, Revenues & Volume, By Breast Cancer, 2021 - 2031 |
6.2.3 North America Precision Pathology Cancer Market, Revenues & Volume, By Lung Cancer, 2021 - 2031 |
6.2.4 North America Precision Pathology Cancer Market, Revenues & Volume, By Prostate Cancer, 2021 - 2031 |
6.2.5 North America Precision Pathology Cancer Market, Revenues & Volume, By Colon Cancer, 2021 - 2031 |
6.3 North America Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Precision Pathology Cancer Market, Revenues & Volume, By Digital Pathology, 2021 - 2031 |
6.3.3 North America Precision Pathology Cancer Market, Revenues & Volume, By Immunohistochemistry, 2021 - 2031 |
6.3.4 North America Precision Pathology Cancer Market, Revenues & Volume, By Whole Slide Imaging, 2021 - 2031 |
6.3.5 North America Precision Pathology Cancer Market, Revenues & Volume, By Fluorescent In Situ Hybridization, 2021 - 2031 |
6.4 North America Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.4.2 North America Precision Pathology Cancer Market, Revenues & Volume, By Diagnostic Services, 2021 - 2031 |
6.4.3 North America Precision Pathology Cancer Market, Revenues & Volume, By Laboratory Services, 2021 - 2031 |
6.4.4 North America Precision Pathology Cancer Market, Revenues & Volume, By In-House Testing, 2020 - 2028 |
6.4.5 North America Precision Pathology Cancer Market, Revenues & Volume, By Third-Party Testing, 2020 - 2028 |
7 North America Precision Pathology Cancer Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.1 United States (US) Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.2 Canada Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.3 Rest of North America Precision Pathology Cancer Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.3 North America Precision Pathology Cancer Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
7.3.1 United States (US) Precision Pathology Cancer Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.2 Canada Precision Pathology Cancer Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3.3 Rest of North America Precision Pathology Cancer Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.4 North America Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
7.4.1 United States (US) Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
7.4.2 Canada Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
7.4.3 Rest of North America Precision Pathology Cancer Market, Revenues & Volume, By Technology Used, 2021 - 2031 |
7.5 North America Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.5.1 United States (US) Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.5.2 Canada Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.5.3 Rest of North America Precision Pathology Cancer Market, Revenues & Volume, By Service Type, 2021 - 2031 |
8 North America Precision Pathology Cancer Market Key Performance Indicators |
9 North America Precision Pathology Cancer Market - Export/Import By Countries Assessment |
10 North America Precision Pathology Cancer Market - Opportunity Assessment |
10.1 North America Precision Pathology Cancer Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Precision Pathology Cancer Market Opportunity Assessment, By Test Type, 2021 & 2031F |
10.3 North America Precision Pathology Cancer Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10.4 North America Precision Pathology Cancer Market Opportunity Assessment, By Technology Used, 2021 & 2031F |
10.5 North America Precision Pathology Cancer Market Opportunity Assessment, By Service Type, 2021 & 2031F |
11 North America Precision Pathology Cancer Market - Competitive Landscape |
11.1 North America Precision Pathology Cancer Market Revenue Share, By Companies, 2022 |
11.2 North America Precision Pathology Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here